The National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, on July 8 launched its COVID-19 Prevention Trials Network, a clinical trials network seeking to enroll thousands of participants in COVID-19 vaccine and antibody treatment testing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,